ResearcherDongguk UniversityActive in the last 2 years

Kyobum Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3678-2078; OpenAlex author ID A5057631043. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

Development of Natural Killer Cell-Drug Conjugates via Membrane-Installed Liposomes for Pancreatic Cancer Treatment. Last author DOI 10.34133/bmr.0285 ↗
Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapy. Last author DOI 10.1186/s40824-022-00282-6 ↗
Exosome-mediated diagnosis of pancreatic cancer using lectin-conjugated nanoparticles bound to selective glycans. Co-author DOI 10.1016/j.bios.2021.112980 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ashok Kumar Jangid · 1 shared paper, 2025 · strength 0.33
- Paper Development of Natural Killer Cell-Drug Conjugates via Membrane-Installed Liposomes for Pancreatic Cancer Treatment. DOI 10.34133/bmr.0285 ↗
Sung Jun Kim · 1 shared paper, 2022 · strength 0.26
- Paper Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapy. DOI 10.1186/s40824-022-00282-6 ↗
Yonghyun Choi · 1 shared paper, 2021 · strength 0.15
- Paper Exosome-mediated diagnosis of pancreatic cancer using lectin-conjugated nanoparticles bound to selective glycans. DOI 10.1016/j.bios.2021.112980 ↗
Jonghoon H. Choi · 1 shared paper, 2021 · strength 0.15
- Paper Exosome-mediated diagnosis of pancreatic cancer using lectin-conjugated nanoparticles bound to selective glycans. DOI 10.1016/j.bios.2021.112980 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.